Shiry Nima, Shomali Tahoora, Soltanian Siyavash, Akhlaghi Mostafa
Department of Aquatic Animal Health and Diseases, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Division of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
J Vet Pharmacol Ther. 2019 Mar;42(2):214-221. doi: 10.1111/jvp.12736. Epub 2018 Nov 25.
This study evaluates changes in the pharmacokinetic behavior of a single oral dose of florfenicol in rainbow trouts experimentally infected with Lactococcus garvieae or Streptococcus iniae. One hundred and fifty fish were randomly divided into three equal groups: 1-healthy fish, 2-fish inoculated with S. iniae (2.87 × 10 CFU/ml, i.p.), and 3-fish inoculated with L. garvieae (6.8 × 10 CFU/ml, i.p.). Florfenicol was administered to all groups at 15 mg/kg by oral gavage. Blood sampling was performed at 0, 2, 3, 6, 8, 12, 24, 48, 72, and 120 hr after drug administration to each group, and plasma concentration of florfenicol was assayed by HPLC method. The MICs of florfenicol were 1.2 μg/ml and 5 μg/ml against L. garviae and S. iniae, respectively. Healthy fish showed higher values for most of the PK/PD parameters as compared to fish infected with L. garvieae which was reversed in fish infected with S. iniae. Fish infected with L. garvieae showed decreased relative bioavailability accompanied by increased volume of distribution at steady-state (Vd ) and total body clearance (Cl ) Infection with S. iniae increased the peak concentration of drug after administration (Cmax) and decreased elimination half-life (T ) central compartment volume (V ), and Vd . In conclusion, infection with these bacteria can affect the pharmacokinetic behavior of florfenicol in rainbow trouts as shown by decreased bioavailability and increased total body clearance and volume of distribution in L. garvieae infection and decreased volume of distribution accompanied by increased Cmax in S. iniae-infected fish.
本研究评估了单剂量口服氟苯尼考在实验性感染停乳链球菌或海豚链球菌的虹鳟鱼体内药代动力学行为的变化。150条鱼被随机分为三组,每组数量相等:1-健康鱼;2-接种海豚链球菌的鱼(腹腔注射,2.87×10 CFU/ml);3-接种停乳链球菌的鱼(腹腔注射,6.8×10 CFU/ml)。所有组均通过口服灌胃给予15mg/kg的氟苯尼考。在给每组鱼给药后的0、2、3、6、8、12、24、48、72和120小时进行采血,并采用高效液相色谱法测定血浆中氟苯尼考的浓度。氟苯尼考对停乳链球菌和海豚链球菌的最低抑菌浓度分别为1.2μg/ml和5μg/ml。与感染停乳链球菌的鱼相比,健康鱼的大多数药代动力学/药效学参数值更高,而感染海豚链球菌的鱼则相反。感染停乳链球菌的鱼相对生物利用度降低,同时稳态分布容积(Vd)和总体清除率(Cl)增加。感染海豚链球菌使给药后药物的峰浓度(Cmax)增加,消除半衰期(T)、中央室容积(V)和Vd降低。总之,这些细菌感染可影响氟苯尼考在虹鳟鱼体内的药代动力学行为,如停乳链球菌感染时生物利用度降低、总体清除率和分布容积增加,而海豚链球菌感染的鱼分布容积降低,Cmax增加。